Back
Day Range
$4.05
$4.34
52-Week Range
$1.32
$5.03
Volume
4,846,654
50D / 200D Avg
$3.82
/
$2.65
Prev Close
$3.97
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -13.8 | 0.4 |
| P/B | 5.4 | 2.9 |
| ROE % | -42.3 | 3.7 |
| Net Margin % | -79.0 | 3.9 |
| Rev Growth 5Y % | 11.8 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$5.42
+29.4%
Low: $5.25
High: $5.50
Forward EPS
-$0.14
Est. Revenue
120 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$0.00
$0.00 – $0.00
|
220 M | 0 |
| FY2029 |
$0.00
$0.00 – $0.00
|
180 M | 0 |
| FY2028 |
-$0.06
-$0.06 – -$0.06
|
150 M | 2 |
Key Takeaways
Revenue grew 11.76% annually over 5 years — strong growth
Debt/Equity of 0.10 — conservative balance sheet
Negative free cash flow of -16.05M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7.20%
Capital efficient — spends only 3.43% of revenue on capex
Growth
Revenue Growth (5Y)
11.76%
Revenue (1Y)18.96%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-42.25%
ROIC-29.95%
Net Margin-78.95%
Op. Margin-88.53%
Safety
Debt / Equity
0.10
Current Ratio3.83
Interest Coverage-58.00
Valuation
P/E Ratio
-13.84
P/B Ratio5.44
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 18.96% | Revenue Growth (3Y) | 21.70% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 11.76% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 97.61M | Net Income (TTM) | -77.06M |
| ROE | -42.25% | ROA | -25.99% |
| Gross Margin | 46.85% | Operating Margin | -88.53% |
| Net Margin | -78.95% | Free Cash Flow (TTM) | -16.05M |
| ROIC | -29.95% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.10 | Current Ratio | 3.83 |
| Interest Coverage | -58.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -13.84 | P/B Ratio | 5.44 |
| P/S Ratio | 10.93 | PEG Ratio | 1.38 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.07B | Enterprise Value | 936.82M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 97.61M | 82.06M | 65.90M | 73.39M | 62.57M |
| Net Income | -77.06M | -72.49M | -133.70M | -168.72M | -32.41M |
| EPS (Diluted) | -0.31 | -0.34 | -0.65 | -0.84 | -0.19 |
| Gross Profit | 45.73M | 48.83M | 16.86M | 39.46M | 17.05M |
| Operating Income | -86.42M | -74.41M | -145.61M | -193.02M | -192.73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 296.53M | 256.08M | 304.27M | 417.57M | 571.97M |
| Total Liabilities | 100.55M | 87.25M | 84.22M | 92.21M | 124.27M |
| Shareholders' Equity | 195.98M | 168.83M | 220.05M | 325.36M | 447.69M |
| Total Debt | 20.40M | 22.84M | 25.03M | 31.89M | 29.08M |
| Cash & Equivalents | 150.49M | 88.78M | 134.64M | 162.56M | 422.84M |
| Current Assets | 249.10M | 192.61M | 231.26M | 357.14M | 511.90M |
| Current Liabilities | 65.12M | 48.22M | 44.27M | 51.33M | 49.83M |